Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.56 +0.19%   SPY: 132.27 +0.05%
Quote Spy TZYM NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Tranzyme (TZYM)

@ 3:27 PM
Click the portfolio to add TZYM:
Close [X]
+ Add TZYM to Portfolio
  
  Last Trade: $3.03 -0.08 (-2.57%)
  Volume: 31,026 288% of avg daily volume
       
  Avg Volume: 10,764
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 3.00 - 3.13
  Open: 3.13
  Previous Close: 3.11
  52-wk Range: 1.68 - 5.64
  Market Cap: 76.5M
  P/E: 0.1
  Div Yield: $0.00 (0.00%)
Indexes
2011 IPOs (0.0%)
Biotechnology Stocks (+0.1%)
Spy TZYM

? Pro holders
? Member holders
? Items submitted
Additional TZYM resources



Customize Links
To see which Pros and tickerspy members own TZYM Sign up now
Latest TZYM Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Tranzyme Pharma Announces First Quarter 2012 Financial Results
TZYM  
Linked by GlobeNewswire - May 10, 04:30PM from (www.globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., May 10, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a late-stage biopharmaceutical  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma to Report First Quarter 2012 Financial Results
TZYM  
Linked by GlobeNewswire - May 03, 05:10AM from (www.globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., May 3, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it will  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma to Present at Upcoming Investor Conferences
TZYM  
Linked by GlobeNewswire - March 22, 05:10AM from (www.globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., March 22, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Vipin  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
24/7 Wall St. Closing Bell
ODC  PEP  PCBC  MIDD  KBH  FCEL  NNBR  CDTI  DIS  TWX  HTH  FSLR  PLOW  ANTH  VELT  TZYM  
Linked by 24/7 Wall St. - March 12, 04:06PM from (247wallst.com)
US markets opened mixed this morning as there was not a big piece of news to drive investors in any particular direction.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Mid-day Movers
PCBC  CDTI  ANTH  TZYM  TUDO  
Linked by 24/7 Wall St. - March 12, 12:21PM from (247wallst.com)
Shortly before noon ET today, the three major US stock indexes are mixed, with the DJIA up about 7.5 points at around12,930,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Morning Movers
PCBC  [ZOLL]  CDTI  TZYM  TUDO  
Linked by 24/7 Wall St. - March 12, 10:18AM from (247wallst.com)
The three major US equities indexes opened slightly higher this morning as investors absorb the aftermath of the Greek debt  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma and Norgine Announce Top-Line Data From ULISES 007, the First of Two Phase 3 Pivotal Trials
TZYM  
Linked by GlobeNewswire - March 12, 05:10AM from (www.globenewswire.com)

RESEARCH TRIANGLE PARK, N.C. and AMSTERDAM, the Netherlands, March 12, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM)  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma Announces Fourth Quarter and Full-Year 2011 Financial Results
TZYM  
Linked by GlobeNewswire - February 28, 04:30PM from (www.globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a late-stage biopharmaceutical  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma and Norgine Complete Enrollment in ULISES 008, the Second of Two Phase 3 Pivotal Trials of Ulimorelin
TZYM  
Linked by GlobeNewswire - February 27, 04:30PM from (www.globenewswire.com)
RESEARCH TRIANGLE PARK, N.C. and AMSTERDAM, the Netherlands, Feb. 27, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM)  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tranzyme Pharma to Present at Upcoming Investor Conferences
TZYM  
Linked by GlobeNewswire - February 21, 05:10AM from (www.globenewswire.com)
RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that Vipin  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource